CausalSentinel

Protein Dossier — IL7 (Interleukin-7)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.165 0.046 3.32e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: M72 Fibroblastic disorders 0.382 0.115 8.93e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertrophic cardiomyopathy (hcm or hocm) 1.02 0.355 0.00396 Wald ratio 1 cis NA
Multiple sclerosis -0.193 0.0793 0.0147 Wald ratio 1 cis NA
Diagnoses - main ICD10: S66 Injury of muscle and tendon at wrist and hand level 0.46 0.202 0.023 Wald ratio 1 cis NA
Platelet count 4.11 1.9 0.0309 Wald ratio 1 cis NA
Femoral neck bone mineral density -0.0789 0.0368 0.0322 Wald ratio 1 cis NA
Sleep duration 0.0198 0.00952 0.0378 Wald ratio 1 cis NA
Schizophrenia -0.106 0.0526 0.0432 Wald ratio 1 cis NA
Diagnoses - main ICD10: K60 Fissure and fistula of anal and rectal regions 0.282 0.139 0.0434 Wald ratio 1 cis NA
Non-cancer illness code self-reported: anxiety or panic attacks -0.291 0.144 0.0437 Wald ratio 1 cis NA
Fasting proinsulin -0.0647 0.0324 0.0455 Wald ratio 1 cis NA
…and 89 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4140_3_2 IL-7 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

50 association rows across 33 traits (50 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Hematological traits (multi-trait analysis) 1e-147 rs111205650 1 GCST90838669 no MR -> candidate analysis
Lymphocyte count 1e-116 rs1441850 9 GCST90002316 no MR -> candidate analysis
Lymphocyte count (UKB data field 30120) 4e-77 rs1441850 2 GCST90468082 no MR -> candidate analysis
Lymphocyte percentage of white cells 4e-65 rs2919917 2 GCST90002389 no MR -> candidate analysis
Platelet-to-lymphocyte ratio 1e-39 rs1441850 1 GCST90056184 no MR -> candidate analysis
Neutrophil percentage of white cells 5e-39 rs1483573 2 GCST90002399 no MR -> candidate analysis
Neutrophils and lymphocytes in blood (confirmatory factor an 3e-33 rs2953475 1 GCST90309369 no MR -> candidate analysis
Lymphocyte-to-monocyte ratio 2e-32 rs1441850 1 GCST90056181 no MR -> candidate analysis
Neutrophill percentage (UKB data field 30200) 3e-30 rs1483573 1 GCST90468093 no MR -> candidate analysis
Neutrophil-to-lymphocyte ratio 6e-30 rs2953475 7 GCST90056182 no MR -> candidate analysis
Circulating CD6 levels 2e-20 rs2919917 1 GCST90859855 no MR -> candidate analysis
KLRB1 protein levels 6e-18 rs1483573 1 GCST90469709 no MR -> candidate analysis
…and 21 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 936 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
epidermodysplasia verruciformis 0.733 established (curated) no MR -> candidate analysis
basal cell carcinoma 0.431 common-variant locus MR: beta=0.208, p=0.0476 (cis)
systemic lupus erythematosus 0.4 common-variant locus no MR -> candidate analysis
cancer 0.365 common-variant locus MR: beta=0.165, p=3.32e-04 (cis)
cardiomyopathy 0.394 common-variant locus MR: beta=1.02, p=0.00396 (cis)
autoimmune disorder of musculoskeletal system 0.4 common-variant locus no MR -> candidate analysis
Genu valgum 0.396 common-variant locus no MR -> candidate analysis
biliary tract disorder 0.396 common-variant locus no MR -> candidate analysis
tricuspid valve disorder 0.396 common-variant locus no MR -> candidate analysis
Genu varum 0.396 common-variant locus no MR -> candidate analysis
color vision disorder 0.389 common-variant locus no MR -> candidate analysis
bone fracture 0.36 common-variant locus no MR -> candidate analysis
Hypercholesterolemia 0.356 common-variant locus MR: beta=-0.0588, p=0.0929 (cis)
alcohol drinking 0.354 common-variant locus no MR -> candidate analysis
knee fracture 0.346 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 11 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=1, LOEUF=0.359 — LoF-INTOLERANT
GWAS Catalog 58 unique SNPs / 116 rows
ClinVar 135 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance